For this reason, it is possible that the inflammasome signaling pathway is a factor in the presentation of Alzheimer’s disease (AD), as increased IL1β was associated with the response to beta-amyloid (Aβ) deposition [42]. The gene discussed is IL1B; the disease is Alzheimer disease.